Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients

Human Immunology

Volumn 73, Issue 9, 2012, Pages 879-883

  Ling, Min ^a   Marfo, Kwaku ^a   Masiakos, Peter ^a   Aljanabi, Aws ^a   Lindower, Joel ^a   Glicklich, Daniel ^a   de Boccardo, Graciela ^a   Greenstein, Stuart ^a   Chapochnick Friedmann, Javier ^a   Kayler, Liise ^a   Kinkhabwala, Milan ^a   Akalin, Enver ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HLA CW ANTIBODY; ANTI HLA DP ANTIBODY; BASILIXIMAB; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY ISOLATION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FLUORESCENCE; GRAFT RECIPIENT; GRAFT SURVIVAL; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIZATION;

ADULT; AGED; FEMALE; HLA-C ANTIGENS; HLA-DP ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; TISSUE DONORS; YOUNG ADULT;

EID: 84865356810     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.320     Document Type: Article

References (21)

1. Marfo K., Lu A., Ling M., Akalin E. Desensitization protocols and their outcome. Clin J Am Soc Nephrol 2011, 6(4):922-936.
2. Gebel H.M., Bray R.A. The evolution and clinical impact of human leukocyte antigen technology. Curr Opin Nephrol Hypertens 2010, 19(6):598-602.
3. Gilbert M., Paul S., Perrat G., Giannoli C., Pouteil Noble C., Morelon E., et al. Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. Transpl Proc 2011, 43(9):3412-3414.
4. Goral S., Prak E.L., Kearns J., Bloom R.D., Pierce E., Doyle A., et al. Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation. Nephrol Dial Transplant 2008, 23(1):390-392.
5. Singh P., Colombe B.W., Francos G.C., Martinez Cantarin M.P., Frank A.M. Acute humoral rejection in a zero mismatch deceased donor renal transplant due to an antibody to an HLA-DP alpha. Transplantation 2010, 90(2):220-221.
6. Thaunat O., Hanf W., Dubois V., McGregor B., Perrat G., Chauvet C., et al. Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. Transpl Immunol 2009, 20(4):209-211.
7. Samaniego M., Mezrich J., Torrealba J., Lorentzen D., Schadde E., Djamali A., et al. C4d-positive acute antibody-mediated rejection due to anti-HLA-DP antibody: a tale of one patient and a review of the University of Wisconsin experience. Clin Transpl 2006, 503-507.
8. Bachelet T., Couzi L., Guidicelli G., Moreau K., Morel D., Merville P., et al. Anti-Cw donor-specific alloantibodies can lead to positive flow cytometry crossmatch and irreversible acute antibody-mediated rejection. Am J Transplant 2011, 11(7):1543-1544.
9. Chapman J.R., Taylor C., Ting A., Morris P.J. Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. Transplantation 1986, 42(1):91-93.
10. Duquesnoy R.J., Marrari M. Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. Transpl Immunol 2011, 24(3):164-171.
11. Couzi L., Araujo C., Guidicelli G., Bachelet T., Moreau K., Morel D., et al. Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay. Transplantation 2011, 91(5):527-535.
12. Tambur A.R., Ramon D.S., Kaufman D.B., Friedewald J., Luo X., Ho B., et al. Perception versus reality?: Virtual crossmatch-how to overcome some of the technical and logistic limitations. Am J Transplant 2009, 9(8):1886-1893.
13. Bryan C.F., Luger A.M., Smith J.L., Warady B.A., Wakefield M., Schadde E., et al. Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. Clin Transplant 2010, 24(1):56-61.
14. Billen E.V., Christiaans M.H., Doxiadis I.I., Voorter C.E., van den Berg-Loonen E.M. HLA-DP antibodies before and after renal transplantation. Tissue Antigens 2010, 75(3):278-285.
15. Frohn C., Fricke L., Puchta J.C., Kirchner H. The effect of HLA-C matching on acute renal transplant rejection. Nephrol Dial Transplant 2001, 16(2):355-360.
16. Tran T.H., Dohler B., Heinold A., Scherer S., Ruhenstroth A., Opelz G. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants. Transplantation 2011, 92(4):419-425.
17. Akalin E., Dinavahi R., Friedlander R., Ames S., de Boccardo G., Sehgal V., et al. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol 2008, 3(4):1160-1167.
18. Akalin E., Ames S., Sehgal V., Murphy B., Bromberg J.S., Fotino M., et al. Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients. Transplantation 2005, 79(6):742.
19. Akalin E., Ames S., Sehgal V., Fotino M., Daly L., Murphy B., et al. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients. Transplantation 2003, 76(10):1444-1447.
20. Lefaucheur C., Loupy A., Hill G.S., Andrade J., Nochy D., Antoine C., et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21(8):1398-1406.
21. Qiu J., Cai J., Terasaki P.I., El-Awar N., Lee J.H. Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads. Transplantation 2005, 80(10):1511-1513.